Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cencora, Inc. stock logo
COR
Cencora
$283.90
-2.9%
$292.87
$218.65
$309.35
$56.66B0.58985,320 shs2.38 million shs
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$76.70
-2.0%
$71.51
$46.36
$83.02
$15.11B0.641,152 shs165 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$261.05
-0.9%
$256.79
$209.38
$283.47
$21.90B0.78876,841 shs527,502 shs
Natera, Inc. stock logo
NTRA
Natera
$138.13
-1.4%
$156.03
$100.22
$183.00
$19.13B1.761.35 million shs2.24 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cencora, Inc. stock logo
COR
Cencora
-2.88%-2.72%-6.13%+0.29%+18.38%
Eurofins Scient stock logo
ERFSF
Eurofins Scient
-2.01%-0.64%+9.55%+18.56%+27.28%
Labcorp Holdings Inc. stock logo
LH
Labcorp
-0.89%-1.12%+1.27%+4.84%+15.68%
Natera, Inc. stock logo
NTRA
Natera
-1.42%-2.01%-12.96%-15.22%+36.87%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cencora, Inc. stock logo
COR
Cencora
4.0514 of 5 stars
1.42.03.33.14.03.31.3
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/AN/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
4.877 of 5 stars
3.34.02.54.23.42.51.9
Natera, Inc. stock logo
NTRA
Natera
3.5884 of 5 stars
3.55.00.00.03.12.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cencora, Inc. stock logo
COR
Cencora
2.75
Moderate Buy$309.839.13% Upside
Eurofins Scient stock logo
ERFSF
Eurofins Scient
2.33
HoldN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.62
Moderate Buy$289.5810.93% Upside
Natera, Inc. stock logo
NTRA
Natera
3.06
Buy$183.7633.04% Upside

Current Analyst Ratings Breakdown

Latest ERFSF, COR, LH, and NTRA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/28/2025
Natera, Inc. stock logo
NTRA
Natera
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$170.00
7/25/2025
Eurofins Scient stock logo
ERFSF
Eurofins Scient
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$282.00 ➝ $305.00
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$290.00 ➝ $310.00
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$285.00 ➝ $300.00
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$283.00 ➝ $306.00
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$290.00 ➝ $302.00
7/18/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$284.00 ➝ $282.00
7/16/2025
Cencora, Inc. stock logo
COR
Cencora
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$313.00 ➝ $330.00
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$260.00
(Data available from 8/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cencora, Inc. stock logo
COR
Cencora
$293.96B0.19$19.30 per share14.71$4.04 per share70.27
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$7.52B1.97$7.06 per share10.86$27.48 per share2.79
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.01B1.67$22.20 per share11.76$101.96 per share2.56
Natera, Inc. stock logo
NTRA
Natera
$1.70B11.12N/AN/A$9.05 per share15.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cencora, Inc. stock logo
COR
Cencora
$1.51B$8.6232.9416.821.450.55%344.71%4.26%N/A
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$439.77MN/A0.0019.52N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$746M$9.0628.8114.881.685.66%15.45%7.02%10/23/2025 (Estimated)
Natera, Inc. stock logo
NTRA
Natera
-$190.43M-$1.47N/AN/AN/A-10.36%-18.29%-11.68%8/7/2025 (Estimated)

Latest ERFSF, COR, LH, and NTRA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Natera, Inc. stock logo
NTRA
Natera
-$0.60N/AN/AN/A$476.84 millionN/A
8/6/2025Q3 2025
Cencora, Inc. stock logo
COR
Cencora
$3.79$4.00+$0.21$3.52$80.34 billion$80.66 billion
7/24/2025Q2 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion
5/8/2025Q1 2025
Natera, Inc. stock logo
NTRA
Natera
-$0.59-$0.50+$0.09-$0.50$446.68 million$501.83 million
5/7/2025Q2 2025
Cencora, Inc. stock logo
COR
Cencora
$4.07$4.42+$0.35$3.68$75.41 billion$75.50 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cencora, Inc. stock logo
COR
Cencora
$2.200.77%N/A25.52%15 Years
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.881.10%N/A31.79%N/A
Natera, Inc. stock logo
NTRA
Natera
N/AN/AN/AN/AN/A

Latest ERFSF, COR, LH, and NTRA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.11%8/28/20259/11/2025
8/6/2025
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.550.75%8/15/20259/3/2025
5/8/2025
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.550.8%5/16/20255/16/20256/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cencora, Inc. stock logo
COR
Cencora
6.01
0.87
0.52
Eurofins Scient stock logo
ERFSF
Eurofins Scient
0.77
1.26
1.19
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.61
1.50
1.32
Natera, Inc. stock logo
NTRA
Natera
N/A
3.87
3.74

Institutional Ownership

CompanyInstitutional Ownership
Cencora, Inc. stock logo
COR
Cencora
97.52%
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Natera, Inc. stock logo
NTRA
Natera
99.90%

Insider Ownership

CompanyInsider Ownership
Cencora, Inc. stock logo
COR
Cencora
10.80%
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Natera, Inc. stock logo
NTRA
Natera
7.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cencora, Inc. stock logo
COR
Cencora
46,000193.82 million172.89 millionOptionable
Eurofins Scient stock logo
ERFSF
Eurofins Scient
62,696192.98 millionN/ANot Optionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
70,00083.10 million82.40 millionOptionable
Natera, Inc. stock logo
NTRA
Natera
4,434136.55 million126.17 millionOptionable

Recent News About These Companies

Natera, Inc. (NASDAQ:NTRA) Insider Sells $398,670.00 in Stock
RBC Capital Reaffirms Their Buy Rating on Natera (NTRA)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cencora stock logo

Cencora NYSE:COR

$283.90 -8.45 (-2.89%)
Closing price 08/6/2025 03:59 PM Eastern
Extended Trading
$284.49 +0.59 (+0.21%)
As of 08/6/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Eurofins Scient stock logo

Eurofins Scient OTCMKTS:ERFSF

$76.70 -1.57 (-2.01%)
As of 08/6/2025 02:32 PM Eastern

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Labcorp stock logo

Labcorp NYSE:LH

$261.05 -2.43 (-0.92%)
Closing price 08/6/2025 03:59 PM Eastern
Extended Trading
$259.88 -1.17 (-0.45%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Natera stock logo

Natera NASDAQ:NTRA

$138.13 -1.99 (-1.42%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$139.04 +0.91 (+0.66%)
As of 06:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.